Visioneering Technologies, Inc.

Visioneering Technologies, Inc. Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision.

With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences. VTI was founded by Dr. Richard A. Griffin, an optometrist, optical engineer and aerospace engineer who has spent 20 years developing VTI’s optical solutions. From Dr. Griffin's design, VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories. VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.

Don’t miss out on the opportunity to attend the Joint Scientific Program/Residents Poster Session on November 8, 1-3 PM ...
11/06/2024

Don’t miss out on the opportunity to attend the Joint Scientific Program/Residents Poster Session on November 8, 1-3 PM in Exhibit Hall H!

🪧 Check out the VTI posters at Academy 2024:

• Board 66: “A Unique Multifocal Contact Lens Design Provides Functional Vision for All Presbyopes”
- What you’ll learn: See how a contact lens can be a unicorn for presbyopes

• Board 74: “Patient Reported Outcomes in a Randomized Controlled Myopia
Progression Study (PROTECT) of a Soft Multifocal Contact Lens”
- What you’ll learn:
- Data confirms happy kids
- No noticeable vision compromise
- No comfort compromise
- Outstanding Year-1 treatment effect

The VTI team also welcomes you to Booth #230 to learn how NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day contact lenses accommodate a range of myopic and presbyopic patients. We look forward to connecting with you in Indianapolis!



VTI-RCT-SM11

Breaking News: Data confirms that kids are happy in NaturalVue Multifocal and it works for Myopia Management Curious to ...
11/05/2024

Breaking News: Data confirms that kids are happy in NaturalVue Multifocal and it works for Myopia Management

Curious to explore these exciting breakthroughs further? Join VTI and Chief Medical Officer, Dr. Ashley Tuan for a new-data presentation at Academy 2024.

• Session Title: “Just Released: New learnings from the PROTECT Clinical Trial in addition to how NaturalVue Multifocal manages myopia in children”
• When: November 8, 8-8:45 AM
• Location: JW Marriott in White River A

You can expect to hear new insights from the PROTECT MPC Clinical Trial, including:

• Pupil size treatment implications, especially relevant for children spending time outdoors
• Clinically relevant adjusted treatment effect (equalized for age, s*x, pupil size, site, factors that may influence myopic progression)
• Children’s subjective responses on quality of life
• The lens’ impact on binocular vision



VTI-RCT-SM11

Just In: NaturalVue Multifocal Delivers 89% (or 0.48 D) Reduction in Refractive Error Progression* Want to hear more gro...
11/04/2024

Just In: NaturalVue Multifocal Delivers 89% (or 0.48 D) Reduction in Refractive Error Progression*

Want to hear more groundbreaking findings? Join us for another exclusive presentation by VTI’s Chief Medical Officer, Dr. Ashley Tuan.

• Session Title: “Just Released: New learnings from the PROTECT Clinical Trial in addition to how NaturalVue Multifocal manages myopia in children”
• When: November 8, 8-8:45 AM
• Location: JW Marriott in White River A



*Adjusted treatment effect (vs. Control) equalized for age, s*x, pupil size, site, factors that may influence myopic progression.

VTI-RCT-SM11

We’re excited to announce our attendance at The American Academy of Optometry annual meeting in Indianapolis on November...
11/01/2024

We’re excited to announce our attendance at The American Academy of Optometry annual meeting in Indianapolis on November 6-9!

We invite you to join a presentation by VTI’s Chief Medical Officer, Dr. Ashley Tuan, as she unveils major discoveries in myopia management from our PROTECT RCT. Here are the details:

• Session Title: “Accommodative Accuracy of Children Wearing Catenary Curve Multifocal Lenses, 1-Year PROTECT Results”
• What You’ll Learn:
- High relative plus in NaturalVue has no negative impact to accommodative accuracy
- NaturalVue normalizes accommodative accuracy for kids who struggle with focus at near
• When: November 7, 8:30-8:45 AM
• Location: Indianapolis Convention Center, Room 240-242



VTI-RCT-SM11

🚨 Myopia is on the rise! 🚨A recent study published by the British Journal of Ophthalmology revealed that 1 in 3 children...
10/16/2024

🚨 Myopia is on the rise! 🚨

A recent study published by the British Journal of Ophthalmology revealed that 1 in 3 children worldwide is now nearsighted. This alarming trend highlights the importance of early intervention in managing myopia progression.

At VTI, we are committed to addressing the rapid increase in the prevalence of myopia. Our NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day contact lenses enhance vision in the short-term while managing myopia long-term.

Read the full CNN article here: https://bit.ly/47JqltI



MKT-VTI-SM59

Didn’t get a chance to meet up with the VTI team at Vision by Design last week?Discover how you can redefine the patient...
10/10/2024

Didn’t get a chance to meet up with the VTI team at Vision by Design last week?

Discover how you can redefine the patient experience with NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day contact lenses, designed to accommodate a range of myopic and presbyopic patients.

Learn more here: https://vtivision.com/practitioner/

We look forward to supporting your practice!

A big thank you to all the dedicated eyecare professionals who connected with us at Vision by Design in Dallas last week...
10/08/2024

A big thank you to all the dedicated eyecare professionals who connected with us at Vision by Design in Dallas last week! It was a pleasure meeting with such a passionate group, all focused on slowing the progression of myopia and delivering better outcomes for patients.



VTI-RCT-SM10

10/01/2024

VTI recently announced the publication of peer-reviewed data from a prospective clinical study with mature presbyopes in Clinical Ophthalmology.

The study concluded that NaturalVue® Enhanced Multifocal provided a wide range of functional vision while maintaining clear distance vision for individuals suffering from advanced presbyopia.

The article entitled, Evaluation of the Functional Visual Range of a Catenary Curve-Based, Extended Depth-of-Focus Contact Lens for Presbyopia, is available online at Clinical Ophthalmology-Dove Press website.

To view the complete peer-reviewed published article, click here: https://ow.ly/gTfE50TAF25.

Visioneering Technologies Inc.’s CEO, Dr. Juan Carlos Aragon, from the International Myopia Conference in Hainan, China ...
10/01/2024

Visioneering Technologies Inc.’s CEO, Dr. Juan Carlos Aragon, from the International Myopia Conference in Hainan, China with Dr. Ashley Tuan, presenting VTI's latest data from the PROTECT RCT. The poster, entitled, “Optical Defocus to Influence the Progression of Myopia and Eye Growth Shows Dosage-Dependency in Children”, authored by Dr. Tuan and Dr. Sally Dillehay, shares data from the 1-Year results of the study.

This is "IMG_4521" by Jobson Medical Information on Vimeo, the home for high quality videos and the people who love them.

Connect with VTI at Vision by Design, hosted by The American Academy of Orthokeratology and Myopia Control, from October...
10/01/2024

Connect with VTI at Vision by Design, hosted by The American Academy of Orthokeratology and Myopia Control, from October 2-5 in Dallas, Texas!

Here’s where to find us:

📍Booth #217

📊 Research Presentation:
• Session Title: “Randomized Controlled Trial Corroborates Real-World Studies Data for Myopia Progression Control Using Catenary Power Profile Contact Lenses”
• When: October 4, 9:40-10 AM
• Where: Reunion GH

🪧 Poster Presentation:
• When: October 4, 4:40-5:10 PM
• Where: Reunion Foyer

We look forward to connecting with you!



VTI-RCT-SM10

We are excited to announce that we will be attending Vision by Design, hosted by The American Academy of Orthokeratology...
09/25/2024

We are excited to announce that we will be attending Vision by Design, hosted by The American Academy of Orthokeratology and Myopia Control, October 2-5 in Dallas, Texas!

Join VTI/NaturalVue for exciting research updates on Friday, October 4th at 9:40-10 AM, featuring Dr. Kuang-mon (Ashley) Tuan, VTI’s Chief Medical Officer. Dr. Tuan will present “Randomized Controlled Trial Corroborates Real-World Studies Data for Myopia Progression Control Using Catenary Power Profile Contact Lenses.”

Later that day, don’t miss our poster session from 4:40-5:10 PM.

Visit us at Booth #217 to discover how NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day contact lenses accommodate a range of myopic and presbyopic patients.



VTI-RCT-SM10

Finally, more support that myopia is a disease and should be treated as such.  Check out the new report from The Nationa...
09/18/2024

Finally, more support that myopia is a disease and should be treated as such. Check out the new report from The National Academies of Sciences, Engineering, and Medicine entitled Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease.

Read chapter Front Matter: Myopia, commonly called nearsightedness, has been increasing globally. If current trends continue, there will be 5 billion near...

Address

10745 Westside Way, Suite 225
Alpharetta, GA
30009

Alerts

Be the first to know and let us send you an email when Visioneering Technologies, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Visioneering Technologies, Inc.:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category